2004
DOI: 10.4067/s0034-98872004001100012
|View full text |Cite
|
Sign up to set email alerts
|

Trastornos del ánimo, psicofármacos y tiroides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
1

Year Published

2006
2006
2018
2018

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 74 publications
0
3
0
1
Order By: Relevance
“…Hypothyroidism is an adverse effect associated with lithium, probably impairing thyroid hormone release, organic binding reaction and also triggering autoimmune thyroiditis [10,20]. However, the clinical and biochemical picture of our patient was compatible with a RTH, but it has not been described, as a side effect of psychiatric drugs [10].…”
Section: Case Reportmentioning
confidence: 89%
See 2 more Smart Citations
“…Hypothyroidism is an adverse effect associated with lithium, probably impairing thyroid hormone release, organic binding reaction and also triggering autoimmune thyroiditis [10,20]. However, the clinical and biochemical picture of our patient was compatible with a RTH, but it has not been described, as a side effect of psychiatric drugs [10].…”
Section: Case Reportmentioning
confidence: 89%
“…Biochemical analyses showed an elevation of T 3 ([800 ng/dl) and TSH suppression (\0.01 lUI/ml). It should be noted that drugs, such as lithium, among others, can affect the thyroid function [10]. Hypothyroidism is an adverse effect associated with lithium, probably impairing thyroid hormone release, organic binding reaction and also triggering autoimmune thyroiditis [10,20].…”
Section: Case Reportmentioning
confidence: 99%
See 1 more Smart Citation
“…Existen numerosos reportes que asocian patologías tiroideas con enfermedades neuropsiquiátricas [6][7][8][9] . La principal asociación que se ha encontrado es entre el hipotiroidismo y depresión 7,9 , describiéndose en Chile una prevalencia de hipotiroidismo de 12% en pacientes consultantes en un centro de psiquiatría ambulatoria y de 23% en pacientes con depresión refractaria a tratamiento 10,11 .…”
unclassified